In the News

June 19, 2025

AI News: Alameda based Infinimmune launched its GLIMPSE-1 antibody engineering platform that is based on a protein language model focused on native human antibody sequences

June 12, 2025

How Infinimmune is Transforming Therapeutic Antibody Engineering

June 12, 2025

Infinimmune’s AI Model GLIMPSE-1 Engineers Human-Sourced Antibodies

April 14, 2025

FDA wants a shift away from animal testing

April 11, 2025

FDA wants to get rid of animal testing requirements for antibody drugs

April 15, 2025

Insight on FDA’s Plan to Phase Out Animal Testing for mAbs and Other Drugs

January 5, 2024

Infinimmune, Grid Therapeutics Strike Antibody-Based Cancer Drug Discovery Partnership

April 19, 2023

Bio’s Next Tool Builders

December 6, 2022

$12-Million Seed Funding to Design Drugs Using Human-Sourced Antibodies

December 6, 2022

Infinimmune’s secret for building better antibody drugs: You